A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™
- 21 June 2002
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 29 (5) , 599-606
- https://doi.org/10.1016/s0969-8051(02)00322-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapyCritical Reviews in Oncology/Hematology, 2001
- Quantitative Imaging of Yttrium-86 with PET The Occurrence and Correction of Anomalous Apparent Activity in High Density RegionsClinical Positron Imaging, 2000
- Synthesis and evaluation of antiproliferative activity of a geldanamycin–Herceptin™ immunoconjugateBioorganic & Medicinal Chemistry Letters, 2000
- Clinical radioimmunotherapySeminars in Radiation Oncology, 2000
- Purification of p-nitrobenzyl C-functionalized diethylenetriamine pentaacetic acids for clinical applications using anion-exchange chromatographyJournal of Chromatography A, 1997
- Quantitative bremsstrahlung imaging of yttrium‐90 using a Wiener filterMedical Physics, 1994
- Production of the positron emitting radioisotope 86Y for nuclear medical applicationApplied Radiation and Isotopes, 1993
- Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugatesBioconjugate Chemistry, 1992
- Human colonic adenocarcinoma cellsIn Vitro Cellular & Developmental Biology - Plant, 1976
- Metabolic Characteristics Within a Chemical FamilyHealth Physics, 1959